Piper Sandler lifts NIC target as shorts rebuild at the margin

Nicolet Bankshares enters the week having just reported Q3 results, with Piper Sandler moving swiftly to raise its price target and short sellers quietly adding exposure over the past month, even as the options market remains overwhelmingly tilted toward calls.

The most immediate development is on the analyst side. Piper Sandler's Nathan Race raised his target to $196 from $194 this morning, maintaining an Overweight rating, a quick post-earnings response after NIC reported yesterday. The broader Street has been directionally positive for much of 2026. Keefe Bruyette raised its Outperform target to $185 in July, and the consensus mean sits at $194, implying roughly 18% upside to Tuesday's close of $164.61. Raymond James initiated at Market Perform in June without a target, the lone note of caution. The bull case centres on projected tangible book value growth of 24% in 2026 and 19% in 2027, margin expansion toward 3.87% NIM by Q4, and rising capital returns through buybacks and dividends. Bears point to a $38 million sequential decline in loans, deteriorating credit quality, and pressure on margins from elevated operating expenses. On valuation, NIC trades at roughly 12.5 times trailing earnings and 1.37 times book, both roughly stable over the past month. The 12-month forward EPS growth factor ranks in the 92nd percentile, a standout score. EPS surprise ranks in the bottom fifth, suggesting the market has generally been ahead of the beat.

Short interest tells a more nuanced story than a first glance suggests. At 7.3% of free float, NIC carries a meaningful short position, and that figure has grown 15% over the past month. Week-on-week the change is minimal, down half a percent, so last week's Q3 announcement has not yet triggered a material flush or add. The lending market is nowhere near strained. Availability is running at 459%, meaning there are more than four shares available to borrow for every share already short, well above the 52-week tightest reading of 161%. Cost to borrow has nudged up about 13% over the week to 0.48%, but that is still firmly in low-cost territory. The ORTEX short score is 51.7, near the midpoint of its range, and has been essentially flat for two weeks. Days to cover on the FINRA fortnightly count was 6.76 at the September 30 settlement date, a moderately elevated figure for a regional bank, but not alarming given the thin trading volume typical of a $3.4 billion market cap name.

Options positioning is decidedly bullish rather than defensive. The put/call ratio has dropped to 0.08, well below its 20-day average of 0.13, and near the lower end of its 52-week range of 0.04 to 1.0. The spike to a PCR of 1.0 on October 19 appears to have been a single-day anomaly, possibly hedging ahead of the earnings print, and it reversed sharply as the result landed without drama. Historical post-earnings reactions for NIC have been muted. The July print produced a 0.5% move the next day and 3.7% over five days. The May print generated 1.8% the day after and 5% over five days. The next earnings event is not until January 12, 2027.

Institutional ownership is worth a brief note. BlackRock added aggressively in the quarter ending September 30, bringing its stake to 14.4% of shares, a position that dwarfs the next-largest holder. State Street filed a fresh 13G in August disclosing a 5.5% passive stake. Neither filing carries activist intent. Goldman Sachs Asset Management added 62,000 shares in the period ending October 1. The insider register is quieter. The 90-day net is negative at roughly 4,200 shares sold and $716,000 in net value, driven by EVP Eric Witczak's open-market sales in late July at prices between $168 and $172, above the current level. Those were discretionary sales, not plan-linked.

The FDIC call report data, covering the bank's own filings through Q2 2026, shows total assets up 73% year-on-year and total deposits up 69%. The ORTEX Alt Data layer flags these as untested against reported figures, meaning no lead relationship has yet been established. They are colour on scale rather than a signal for the next print.

With Q3 now out and analyst targets just refreshed, the next focal point is loan book trajectory and whether the sequential decline in commercial and industrial loans stabilises or deepens into Q4, a question that will define whether the NIM expansion story or the credit quality concern wins out by the January print.